2026 Q2 -tulosraportti
Vain PDF
54 päivää sitten
Tarjoustasot
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 4 | - | - | ||
| 12 | - | - | ||
| 4 | - | - | ||
| 12 | - | - | ||
| 4 | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Rahastot ja ETF:t, joilla on osaketta
Mikään rahasto ei ilmoita osaketta kymmenen suurimman omistuksensa joukossa.
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 8 731 | 8 731 | 0 | 0 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 8 731 | 8 731 | 0 | 0 |
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q3 -tulosraportti 15.10. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q2 -tulosraportti 9.7. | ||
2026 Q1 -tulosraportti 15.4. | ||
2025 Q4 -tulosraportti 21.1. | ||
2025 Q3 -tulosraportti 22.10.2025 | ||
2025 Q2 -tulosraportti 31.7.2025 |
Asiakkaat katsoivat myös
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
·17 t sittenWhich stocks does Einhorn think should be sold off? My comment on today's share price drop: The drop is somewhat incomprehensible. Nanologica is undeservedly taking a lot of share price hits today, but theoretically, all else being equal, it should only result in a share price drop for Flerie of 0.6%. Since the net asset value discount is over 50%, the drop should realistically only have been 0.3%
·21.8.Confidence in the CEO is apparently sinking day by day.What do you think the CEO should do besides communicating more clearly and not choosing totally opaque solutions, such as acquisition of shares and issuing bonus shares, which admittedly has made the intrinsic value per share higher, but at the same time has halved the share price currently.- ·19.8. · MuokattuCalm down! Xspray's share price drop should only have an impact today of 0.6 - 0.7 % on Flerie's share price. Use ibindex.se. Today's share price drop for Flerie to 19.1 is an overreaction.
- ·7.8. · MuokattuPartly, the price of medtech is low, as someone writes. Not least unlisted medtech companies. Partly, Flerie and its main shareholder tried to make the share more attractive and reduce the substance discount, so that the price came closer to the substance value - but the technique was hopelessly opaque for journalists and ordinary market participants and unfortunately ended with the price falling further and the substance discount becoming even higher. Today's low price is due to a difficult-to-understand process, where shareholders received a "payout" of part of the cash holdings and subsequently received additional shares at the main shareholder's expense - without the market and journalists really being able to understand and calculate what the new price should be. It may therefore take a long time before the price of Flerie recovers - but it should. It doesn't get any better that foolish journalists and AI keep driving the share price down when they compare current substance value with last year's substance value without mentioning or recalculating the fall in relation to last year's price in relation to "payout" and free shares since then. I made this updated analysis on 30.06.2026: "The ”real substance discount” is currently 71 % at today's price of 20.20 SEK. This means that you get the unlisted shares for less than 1/3 of the current value. The official substance discount calculated by ibindex.se is 51 % as of today. But note that I do not calculate the discount in the same way as ibindex, as I instead use what I call the real substance discount. I calculate the ”real substance discount” solely in relation to the unlisted shares, by first fully offsetting the value of the listed shares and positive capital including receivables (and offsetting any debt.) After that, it is of course necessary to look at what unlisted shares are in the company's portfolio, and one must consider whether the value is correctly determined. I do not have the prerequisites to know this, and must therefore assess whether I find the management and critics credible and competent, including the extent to which the management itself invests, and whether there are larger investors who sometimes supplement further." DNB Carnegie lowered the target price for Flerie to 26 kronor on July 10, but reiterates buy. At that price, the discount will still be very high.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2026 Q2 -tulosraportti
Vain PDF
54 päivää sitten
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·17 t sittenWhich stocks does Einhorn think should be sold off? My comment on today's share price drop: The drop is somewhat incomprehensible. Nanologica is undeservedly taking a lot of share price hits today, but theoretically, all else being equal, it should only result in a share price drop for Flerie of 0.6%. Since the net asset value discount is over 50%, the drop should realistically only have been 0.3%
- ·21.8.Confidence in the CEO is apparently sinking day by day.What do you think the CEO should do besides communicating more clearly and not choosing totally opaque solutions, such as acquisition of shares and issuing bonus shares, which admittedly has made the intrinsic value per share higher, but at the same time has halved the share price currently.
- ·19.8. · MuokattuCalm down! Xspray's share price drop should only have an impact today of 0.6 - 0.7 % on Flerie's share price. Use ibindex.se. Today's share price drop for Flerie to 19.1 is an overreaction.
- ·7.8. · MuokattuPartly, the price of medtech is low, as someone writes. Not least unlisted medtech companies. Partly, Flerie and its main shareholder tried to make the share more attractive and reduce the substance discount, so that the price came closer to the substance value - but the technique was hopelessly opaque for journalists and ordinary market participants and unfortunately ended with the price falling further and the substance discount becoming even higher. Today's low price is due to a difficult-to-understand process, where shareholders received a "payout" of part of the cash holdings and subsequently received additional shares at the main shareholder's expense - without the market and journalists really being able to understand and calculate what the new price should be. It may therefore take a long time before the price of Flerie recovers - but it should. It doesn't get any better that foolish journalists and AI keep driving the share price down when they compare current substance value with last year's substance value without mentioning or recalculating the fall in relation to last year's price in relation to "payout" and free shares since then. I made this updated analysis on 30.06.2026: "The ”real substance discount” is currently 71 % at today's price of 20.20 SEK. This means that you get the unlisted shares for less than 1/3 of the current value. The official substance discount calculated by ibindex.se is 51 % as of today. But note that I do not calculate the discount in the same way as ibindex, as I instead use what I call the real substance discount. I calculate the ”real substance discount” solely in relation to the unlisted shares, by first fully offsetting the value of the listed shares and positive capital including receivables (and offsetting any debt.) After that, it is of course necessary to look at what unlisted shares are in the company's portfolio, and one must consider whether the value is correctly determined. I do not have the prerequisites to know this, and must therefore assess whether I find the management and critics credible and competent, including the extent to which the management itself invests, and whether there are larger investors who sometimes supplement further." DNB Carnegie lowered the target price for Flerie to 26 kronor on July 10, but reiterates buy. At that price, the discount will still be very high.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 4 | - | - | ||
| 12 | - | - | ||
| 4 | - | - | ||
| 12 | - | - | ||
| 4 | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Rahastot ja ETF:t, joilla on osaketta
Mikään rahasto ei ilmoita osaketta kymmenen suurimman omistuksensa joukossa.
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 8 731 | 8 731 | 0 | 0 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 8 731 | 8 731 | 0 | 0 |
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q3 -tulosraportti 15.10. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q2 -tulosraportti 9.7. | ||
2026 Q1 -tulosraportti 15.4. | ||
2025 Q4 -tulosraportti 21.1. | ||
2025 Q3 -tulosraportti 22.10.2025 | ||
2025 Q2 -tulosraportti 31.7.2025 |
2026 Q2 -tulosraportti
Vain PDF
54 päivää sitten
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q3 -tulosraportti 15.10. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q2 -tulosraportti 9.7. | ||
2026 Q1 -tulosraportti 15.4. | ||
2025 Q4 -tulosraportti 21.1. | ||
2025 Q3 -tulosraportti 22.10.2025 | ||
2025 Q2 -tulosraportti 31.7.2025 |
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·17 t sittenWhich stocks does Einhorn think should be sold off? My comment on today's share price drop: The drop is somewhat incomprehensible. Nanologica is undeservedly taking a lot of share price hits today, but theoretically, all else being equal, it should only result in a share price drop for Flerie of 0.6%. Since the net asset value discount is over 50%, the drop should realistically only have been 0.3%
- ·21.8.Confidence in the CEO is apparently sinking day by day.What do you think the CEO should do besides communicating more clearly and not choosing totally opaque solutions, such as acquisition of shares and issuing bonus shares, which admittedly has made the intrinsic value per share higher, but at the same time has halved the share price currently.
- ·19.8. · MuokattuCalm down! Xspray's share price drop should only have an impact today of 0.6 - 0.7 % on Flerie's share price. Use ibindex.se. Today's share price drop for Flerie to 19.1 is an overreaction.
- ·7.8. · MuokattuPartly, the price of medtech is low, as someone writes. Not least unlisted medtech companies. Partly, Flerie and its main shareholder tried to make the share more attractive and reduce the substance discount, so that the price came closer to the substance value - but the technique was hopelessly opaque for journalists and ordinary market participants and unfortunately ended with the price falling further and the substance discount becoming even higher. Today's low price is due to a difficult-to-understand process, where shareholders received a "payout" of part of the cash holdings and subsequently received additional shares at the main shareholder's expense - without the market and journalists really being able to understand and calculate what the new price should be. It may therefore take a long time before the price of Flerie recovers - but it should. It doesn't get any better that foolish journalists and AI keep driving the share price down when they compare current substance value with last year's substance value without mentioning or recalculating the fall in relation to last year's price in relation to "payout" and free shares since then. I made this updated analysis on 30.06.2026: "The ”real substance discount” is currently 71 % at today's price of 20.20 SEK. This means that you get the unlisted shares for less than 1/3 of the current value. The official substance discount calculated by ibindex.se is 51 % as of today. But note that I do not calculate the discount in the same way as ibindex, as I instead use what I call the real substance discount. I calculate the ”real substance discount” solely in relation to the unlisted shares, by first fully offsetting the value of the listed shares and positive capital including receivables (and offsetting any debt.) After that, it is of course necessary to look at what unlisted shares are in the company's portfolio, and one must consider whether the value is correctly determined. I do not have the prerequisites to know this, and must therefore assess whether I find the management and critics credible and competent, including the extent to which the management itself invests, and whether there are larger investors who sometimes supplement further." DNB Carnegie lowered the target price for Flerie to 26 kronor on July 10, but reiterates buy. At that price, the discount will still be very high.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 4 | - | - | ||
| 12 | - | - | ||
| 4 | - | - | ||
| 12 | - | - | ||
| 4 | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Rahastot ja ETF:t, joilla on osaketta
Mikään rahasto ei ilmoita osaketta kymmenen suurimman omistuksensa joukossa.
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 8 731 | 8 731 | 0 | 0 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 8 731 | 8 731 | 0 | 0 |